Browsing Centre for Translational Medicine & Therapeutics by Author "Fagbodun, EO"

Now showing items 1-2 of 2

    • Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials. 

      LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators; Adhikari, NKJ; Hashmi, M; Tirupakuzhi Vijayaraghavan, BK; Haniffa, R; Beane, A; Webb, SA; Angus, DC; Gordon, AC; Cook, DJ (2023-10-25)
      IMPORTANCE: The efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain. OBJECTIVE: To determine whether vitamin C improves outcomes for patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS: Two ...

    • Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. 

      Writing Committee for the REMAP-CAP Investigators; Higgins, AM; Berry, LR; Lorenzi, E; Murthy, S; McQuilten, Z; Mouncey, PR; Al-Beidh, F; Annane, D; Arabi, YM (2023-01-03)
      IMPORTANCE: The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown. OBJECTIVE: To determine the effect of multiple interventions for critically ill adults with COVID-19 ...